Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Akadeum develops bioseparation products to facilitate the removal of target cells from biological samples.
Avation Medical develops medical devices focused on treating gastrointestinal disorders through non-invasive neuromodulation technology.
SonarMD provides care management for chronic conditions that use drugs.
Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.
Boomerang Medical is a bioelectronic medical enterprise.
Flosonics is a medical device company that focuses on developing non-invasive sensors to improve the management of critically ill patients.
Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.
Fifth Eye develops a medical device software that provides a view of a patient’s evolving hemodynamic trajectory.
Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.
Orasis Pharmaceuticals is an ophthalmic pharmaceutical company that develops eye drops for the treatment of presbyopia.
RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.
AtaCor Medical is a medical device maker.
ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma.
Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
Delphinus Medical Technologies develops, commercializes, and services breast cancer screening solutions to hospitals and imaging clinics.
Convergent Dental develops a computer-guided, laser-based drilling, and cutting system for dentists.
Brightspec provides analytical chemistry solutions using FT-MRR spectroscopy, a new commercial technique for direct.
ArborMetrix is a performance measurement for Acute and Specialty Care.
Navv Systems is a provider of indoor location technology for hospitals and health systems.
Enumera Molecular is developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests.
ConcertoCare is a provider of at-home and comprehensive care for seniors and other adults.
Arboretum Ventures has invested in 45 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Arboretum Ventures's top investment sectors include Health Care, Medical, Medical Device, Biotechnology, Pharmaceutical. The firm invests across 26 different industry categories.
Among tracked funding rounds, ConcertoCare received $105.0M in a Series B round. Arboretum Ventures's total known invested capital is $1.4B.
Arboretum Ventures's average investment size is $30.8M across its portfolio of 45 companies.
Recent Arboretum Ventures portfolio additions include Akadeum Life Sciences, Avation Medical, SonarMD, Pharaoh Neuro, Boomerang Medical. These companies were founded in 2020 or later.